Granules of 99.99 percent pure gold are seen at the Krastsvetmet non-ferrous metals plant, one of the world's largest producers in the precious metals industry, in the Siberian city of Krasnoyarsk, Russia November 22, 2018. Picture taken November 22, 2018. REUTERS/Ilya Naymushin - RC121901F300

live

bselive
nselive

Volume

Todays L/H

Sharekhan has come out with its fourth quarter (January-March’ 21) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Granules to report net profit at Rs. 122.7 crore up 253.6% year-on-year (down 16.4% quarter-on-quarter).

Net Sales are expected to increase by 36.2 percent Y-o-Y (down 3.2 percent Q-o-Q) to Rs. 817.2 crore, according to Sharekhan.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Granules Q4 PAT seen up 253.6% YoY to Rs. 122.7 cr: Sharekhan

Net Sales are expected to increase by 36.2 percent Y-o-Y (down 3.2 percent Q-o-Q) to Rs. 817.2 crore, according to Sharekhan.

Granules of 99.99 percent pure gold are seen at the Krastsvetmet non-ferrous metals plant, one of the world's largest producers in the precious metals industry, in the Siberian city of Krasnoyarsk, Russia November 22, 2018. Picture taken November 22, 2018. REUTERS/Ilya Naymushin - RC121901F300